Background The World Health Organization recommends uncomplicated P. falciparum
malaria is treated using Artemisinin‐based Combination Therapy (ACT). This review aims to …

Since ancient times, humankind has had to struggle against the persistent onslaught of
pathogenic microorganisms. Nowadays, malaria is still the most important infectious disease …

Background Sub-Saharan Africa has the highest burden of malaria in the world. Artemisinin-
based combination therapies (ACTs) have been the cornerstone in the efforts to reduce the …

Malaria continues to be a potentially fatal threat to almost half of the world's population. In
light of this threat, the armory to fight this disease is rather limited. Resistance against the …

Malaria is the world's most prevalent disease that affects 515-600 million people each year
and about 40% of the world's population live at risk for this infection. The prevalence of …

Background. Combination antimalarial therapy is advocated to improve treatment efficacy
and limit selection of drug-resistant parasites. We compared the efficacies of 3 combination …

An innovative methodology based on design of experiments (DoE), independent component
analysis (ICA) and design space (DS) was developed in previous works and was tested out …

Applications of Targeted Nano-Drugs and Delivery Systems: Nanoscience and
Nanotechnology in Drug Delivery explores the applications of Nano-drugs and their delivery …

Background Improving the health of school-aged children can yield substantial benefits for
cognitive development and educational achievement. However, there is limited …

Background The use of drug combinations, including non-artemisinin-based and artemisinin-
based combination therapy (ACT), is a novel strategy that enhances therapeutic efficacy and …